Drugs / transfluthrin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06179732 | Jun → Dec 2023 | childhood acute lymphoblastic leukemia, malaria | The Mentor Initiative | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | transfluthrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06179732 ↗ |
| Modality | Small molecule | “transfluthrin, a fast-acting volatile pyrethroid” NCT06179732 ↗ |
| Route | Other | “The chemical passively releases into the air” NCT06179732 ↗ |